image: Targeting Microbiota 2024 will be held on October 14-15, 2024 at Corinthia Palace Malta, featuring a critical workshop titled “Probiotic Prescribing Practices: Empowering Medical Doctors for Improved Patient Health”, aimed at medical professionals.
Credit: International Society of Microbiota
The International Society of Microbiota (ISM) announces its 11th World Congress, "Targeting Microbiota 2024", scheduled for October 14-15 at the Corinthia Palace in Malta. This event is set to highlight the latest research and developments in microbiotal medicine, emphasizing its impact on human health and its potential in shaping future medical treatment approaches.
Detailed Workshop: Probiotic Prescribing Practices dedicated to Medical Professionals
The congress will feature a critical workshop on October 15, titled “Probiotic Prescribing Practices: Empowering Medical Doctors for Improved Patient Health.” Aimed at medical professionals, this workshop intends to provide a better understanding of the clinical applications of microbiota research, focusing on probiotic prescription and its future role in health management and disease treatment. The session will cover a series of important questions:
- How can we incorporate the latest research on the microbiome for the best outcomes?
- What challenges and opportunities exist in the current use of probiotics?
- In what ways can next-generation probiotics and metabolites revolutionize patient care?
- How do we select and provide the right probiotics or metabolites to patients in 2024?
- How can patient education on probiotics be improved for better self-management?
- What role do probiotics play in personalized medicine and patient-specific treatments?
- How can regulatory standards for probiotic products be enhanced to ensure quality and efficacy?
- How to ensure marketing does not overshadow evidence-based probiotic benefits?
- What is the optimal mode of probiotic administration: tablets, food, or fermented products?
- What are the established safety limits for probiotic consumption?
Roundtable Discussion: The effectiveness of a one-size-fits-all approach to probiotic supplementation will be critically evaluated, considering the variability in individual health needs and responses.
Among Speakers
- Martin Lössner, ETH Zurich, Switzerland – “Phage Therapy: Emerging Applications and Challenges”
- Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan – “Gut Microbiome, Obesity and Diabetes”
- Andreas Schwiertz, Institute of Microecology, Germany – “Probiotics & Health: How to Select the Right Strain?”
- Alan Walker, University of Aberdeen, United Kindgom – “Human Microbiome Myths and Misconceptions”
- Justus Reunanen, University of Oulu, Finland – “Microbiota-Derived Extracellular Vesicles: Bridging Mother and Fetus”
- Koen Venema, Editor-in-chief of Beneficial Microbes, Netherlands – “Sophisticated in vitro Models of the Gastrointestinal Tract to Study the Role of the Gut Microbiota in Health and Disease”
- Patrick C. H. Hsieh, Academia Sinica, Tawian – “Gut Bacteria and Heart Healing: The Hidden Players in Post-Infarction Resilience”
- Souhaila Al Khodor, Sidra Medicine, Qatar – “The Oral-Placental Microbiome Axis in Preterm Birth”
- Christian Riedel, University of Ulm, Germany – “Novel Antimicrobial Peptides: Biomedical Applications and Role in Shaping Microbiomes in Complex Ecosystems”
For more details on the congress agenda, speakers, registration instructions, abstract submission guidelines, and other pertinent information, please visit the event's official website at www.microbiota-site.com.
Contact Information
Questions and inquiries can be directed to the International Society of Microbiota at microbiota@microbiota-ism.com.
More about the International Society of Microbiota
- ISM Membership
- ISM 2023 Awards
- Conclusion of Targeting Microbiota 2023
- Abstracts and Replay of Targeting Microbiota 2023
- ISM Newsletters
- ISM Press Releases